Journal of biomedical research · 2026
Human serum albumin modified in myeloperoxidase-dependent reactions is a mediator of neutrophil extracellular trap formation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grigorieva Daria V, Gorbunov Nikolay P, Kostevich Valeria A, Sokolov Alexey V, Basyreva Liliya Yu, Shmeleva Ekaterina V, Vakhrusheva Tatyana V, Gusev Sergey A, Gorudko Irina V, Panasenko Oleg M
Аннотация
Activation of neutrophil membrane receptors initiates intracellular signal transduction cascades that orchestrate the cell's effector functions, including phagocytosis, production of reactive oxygen and halogen species, degranulation, and NETosis (formation of neutrophil extracellular traps [NETs]). NETs, which contain antimicrobial compounds such as myeloperoxidase (MPO), represent a strategy to combat infection. However, excessive production of NETs promotes thrombosis, diabetes mellitus, and other diseases. Therefore, investigations into the mechanisms of NETosis and the identification of modulators of this process are critical for developing strategies to address NETosis-related disorders. Here, we identified a novel NETosis inducer, human serum albumin (HSA) modified by the MPO product hypochlorous acid (HSA HOCl), whose accumulation in vivo was correlated with inflammatory processes. Using human blood neutrophils, we investigated HSA HOCl-induced NETosis and detected NET formation by flow cytometry. The results showed that the mechanism of HSA HOCl-induced NETosis involved MPO, NADPH oxidase, and phosphatidylinositol 3-kinases (PI3Ks), and that HSA HOCl activated a reactive oxygen species-dependent suicidal type of NETosis. Moreover, HSA HOCl-induced NETosis was inhibited by an anti-HSA HOCl monoclonal antibody. Thus, our findings may facilitate the development of strategies to modulate NETosis in inflammation associated with elevated MPO activity.